リコンビナント
RabMAb

Anti-Met (c-Met) (phospho Y1349) 抗体 [EP2367Y] (ab68141)

ab68141 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab68141 は 5 報の論文で使用されています。

  • Cheng ZX  et al. MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma. Int J Mol Med 40:1307-1314 (2017). PubMed: 28901390
  • Pei J  et al. Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells. Yonsei Med J 58:581-591 (2017). WB ; Human . PubMed: 28332364
  • Majumder B  et al. Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nat Commun 6:6169 (2015). IHC-P ; Human . PubMed: 25721094
  • Gerdes MJ  et al. Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue. Proc Natl Acad Sci U S A 110:11982-7 (2013). ICC/IF ; Human . PubMed: 23818604
  • Dienstmann R  et al. Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials. Mol Cancer Ther 11:2062-71 (2012). PubMed: 22723336

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録